The DOI matches its Crossref record.
1α,25‐Dihydroxyvitamin D 3 modulates human adipocyte metabolism via nongenomic action
Abstract
We reported recently that suppression of the renal lα,25‐dihyroxyvitamin D 3 (lα,25‐(OH) 2 ‐D 3 ) production in aP2‐agouti transgenic mice by increasing dietary calcium decreases adipocyte intracellular Ca 2+ ([Ca 2+ ]i), stimulates lipolysis, inhibits lipogenesis, and reduces adiposity. However, it was not clear whether this modulation of adipocyte metabolism by dietary calcium is a direct effect of inhibition of lα,25‐(OH) 2 ‐D 3 ‐induced [Ca 2+ ]i. Accordingly, we have now evaluated the direct role of lα,25‐(OH) 2 ‐D 3 . Human adipocytes exhibited a lα,25‐(OH) 2 ‐D 3 dose‐responsive (1–50 nM) increase in [Ca 2+ ]i ( P < 0.01). This action was mimicked by lα,25‐dihyroxylumisterol 3 (lα,25‐(OH) 2 ‐lumisterol 3 ) ( P < 0.001), a specific agonist for a putative membrane vitamin D receptor (mVDR), and completely prevented by lβ,25‐dihydroxyvitamin D 3 (1β,25‐(OH )2 ‐D 3 ), a specific antagonist for the mVDR. Similarly, lα,25‐(OH )2 ‐D 3 (5 nM) caused 50%‐100% increases in adipocyte fatty acid synthase (FAS) expression and activity ( P < 0.02), a 61% increase in glycerol‐3‐phosphate dehydrogenase (GPDH) activity ( P < 0.01), and an 80% inhibition of isoproterenol‐stimulated lipolysis ( P < 0.001), whereas lβ,25‐(OH) 2 ‐D 3 completely blocked all these effects. Notably, lα,25‐(OH) 2 ‐lumisterol 3 exerted more potent effects in modulating adipocyte lipid metabolism, with 2.5‐ to 3.0‐fold increases in FAS expression and activity ( P < 0.001) and a threefold increase in GPDH activity ( P < 0.001). Also l α,25‐(OH)2‐lumisterol3 was approximately twice as potent in inhibiting basal lipolysis ( P < 0.025), whereas lβ,25‐(OH) 2 ‐D 3 completely blocked all these effects. These data suggest that l α,25‐(OH)2‐D3 modulates adipocyte Ca 2+ signaling and, consequently, exerts a coordinated control over lipogenesis and lipolysis. Thus, a direct inhibition of l α,25‐(OH) 2 ‐D 3 ‐induced [Ca 2+ ]i may contribute to an anti‐obesity effect of dietary calcium, and the mVDR may represent an important target for obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Vitamin D metabolism, mechanism of action, and clinical applications
Bikle, D. D. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.12.016 · Cited by 1,933
Vimaleswaran, K. S., Berry, D. J., Lu, C., Tikkanen, E., Pilz, S., Hiraki, L. T., Cooper, J. D., Dastani, Z., Li, R., Houston, D. K., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001383 · Cited by 1,046
The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement
Rosen, C. J., Adams, J. S., Bikle, D. D., Black, D. M., Demay, M. B., Manson, J. E., Murad, M. H., & Kovacs, C. S. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1000 · Cited by 765
The Relationship between Obesity and Serum 1,25-Dihydroxy Vitamin D Concentrations in Healthy Adults
Parikh, S. J., Edelman, M., Uwaifo, G. I., Freedman, R. J., Semega-Janneh, M., Reynolds, J., & Yanovski, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031398 · Cited by 660
Calcium and Dairy Acceleration of Weight and Fat Loss during Energy Restriction in Obese Adults
Zemel, M. B., Thompson, W., Milstead, A., Morris, K., & Campbell, P. (2004) · Obesity Research · doi:10.1038/oby.2004.67 · Cited by 601
Self-citation
Metadata
- Authors
- Shi, H., Norman, A. W., Okamura, W. H., Sen, A., & Zemel, M. B.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-10-15
- Volume
- 15
- Issue
- 14
- Pages
- 1-15
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2156807491
- Cited by
- 253
- References
- 0
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 1α,25‐Dihydroxyvitamin D 3 modulates human adipocyte metabolism via nongenomic action. https://app.cochat.ai/papers/10.1096/fj.01-0584fje
- The paper
- Shi, H., Norman, A. W., Okamura, W. H., Sen, A., & Zemel, M. B. (2001). 1α,25‐Dihydroxyvitamin D 3 modulates human adipocyte metabolism via nongenomic action. The FASEB Journal. https://doi.org/10.1096/fj.01-0584fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.